Axil Capital
Overview
Axil Capital is a venture capital firm based in Tokyo, Japan, that was spun out of Mizuho Securities in 2017. It specializes in investments in the biomedical and healthcare technology sectors, investing across all stages from seed to crossover rounds. The firm invests globally in areas including biopharmaceuticals, platform technologies, medical devices, and digital health.
Portfolio Companies
11
Website
axilcapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| C4 Therapeutics | Jun 2020 | Series B | Co-investor |
| Fore Biotherapeutics | Jul 2026 | Series D-2 Extension | Co-investor |
| Jolly Good Inc. | Jan 2021 | Series C | Co-investor |
| CynosBio, Inc. | Jul 2024 | Series C | Lead |
| United Immunity, Co., Ltd. | Dec 2020 | Series A Extension | Co-investor |
For institutional investors. Book with your work email.
Key People
Joon Paek
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Axil Capital based?
Axil Capital is headquartered in Tokyo, Tokyo, Japan.
When was Axil Capital founded?
Founding year information for Axil Capital is not publicly available.
How many portfolio companies does Axil Capital have?
Axil Capital has 11 portfolio companies in Caplight's dataset.
What are some companies in Axil Capital's portfolio?
Portfolio companies visible on Caplight include C4 Therapeutics, Fore Biotherapeutics, Jolly Good Inc., CynosBio, Inc., United Immunity, Co., Ltd..
What was Axil Capital's most recent investment shown here?
Axil Capital's most recent investment in this portfolio sample was in Fore Biotherapeutics in 2026.
What sectors does Axil Capital focus on?
Axil Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Enterprise Software, Enterprise Software.
What company stages does Axil Capital focus on?
Axil Capital typically invests at the Mid stage.